No biomarker	Soft Tissue Sarcoma	No biomarker	Soft Tissue Sarcoma	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1
No biomarker	Ovarian Cancer	No biomarker	Ovarian Cancer	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1
No biomarker	Leiomyosarcoma	No biomarker	Leiomyosarcoma	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1
No biomarker	Liposarcoma	No biomarker	Liposarcoma	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1	trabectedin Sensitive: A1 - Approval trabectedin Sensitive : A1
No biomarker	Peritoneal Cancer	No biomarker	Peritoneal Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Fallopian Tube Cancer	No biomarker	Fallopian Tube Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Sarcoma	No biomarker	Sarcoma	trabectedin Sensitive: A2 - Guideline trabectedin Sensitive : A2	trabectedin Sensitive: A2 - Guideline trabectedin Sensitive : A2
No biomarker	Thymic Carcinoma	No biomarker	Thymic Carcinoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Small Cell Lung Cancer	No biomarker	Small Cell Lung Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Hodgkin Lymphoma	No biomarker	Hodgkin Lymphoma	carboplatin + etoposide oral + bendamustine Sensitive: A2 - Guideline carboplatin + etoposide oral + bendamustine Sensitive : A2	carboplatin + etoposide oral + bendamustine Sensitive: A2 - Guideline carboplatin + etoposide oral + bendamustine Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2
No biomarker	T Acute Lymphoblastic Leukemia	No biomarker	T Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2	cyclophosphamide + etoposide oral + nelarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + nelarabine Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2
No biomarker	Merkel Cell Carcinoma	No biomarker	Merkel Cell Carcinoma	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	trabectedin Sensitive: A2 - Guideline trabectedin Sensitive : A2	trabectedin Sensitive: A2 - Guideline trabectedin Sensitive : A2
No biomarker	Rhabdomyosarcoma	No biomarker	Rhabdomyosarcoma	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Kaposi Sarcoma	No biomarker	Kaposi Sarcoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Osteosarcoma	No biomarker	Osteosarcoma	ifosfamide + methotrexate + etoposide oral Sensitive: A2 - Guideline ifosfamide + methotrexate + etoposide oral Sensitive : A2	ifosfamide + methotrexate + etoposide oral Sensitive: A2 - Guideline ifosfamide + methotrexate + etoposide oral Sensitive : A2
No biomarker	Testicular Cancer	No biomarker	Testicular Cancer	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2	etoposide oral Sensitive: A2 - Guideline etoposide oral Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Prostate Cancer	No biomarker	Prostate Cancer	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2	carboplatin + etoposide oral Sensitive: A2 - Guideline carboplatin + etoposide oral Sensitive : A2
No biomarker	Cervical Cancer	No biomarker	Cervical Cancer	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2	cyclophosphamide + etoposide oral + clofarabine Sensitive: A2 - Guideline cyclophosphamide + etoposide oral + clofarabine Sensitive : A2
No biomarker	B Acute Lymphoblastic Leukemia	No biomarker	B Acute Lymphoblastic Leukemia	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2	ifosfamide + etoposide oral + mitoxantrone Sensitive: A2 - Guideline ifosfamide + etoposide oral + mitoxantrone Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline cyclophosphamide + etoposide oral Sensitive : A2	cyclophosphamide + etoposide oral Sensitive: A2 - Guideline cyclophosphamide + etoposide oral Sensitive : A2
No biomarker	Medulloblastoma	No biomarker	Medulloblastoma	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide oral Sensitive : A2	carboplatin + cyclophosphamide + etoposide oral Sensitive: A2 - Guideline carboplatin + cyclophosphamide + etoposide oral Sensitive : A2
No biomarker	Merkel Cell Carcinoma	No biomarker	Merkel Cell Carcinoma	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2	cisplatin + etoposide oral Sensitive: A2 - Guideline cisplatin + etoposide oral Sensitive : A2
BRCA2 mutation	Ovarian Cancer	BRCA2 mutation	Ovarian Cancer	trabectedin Sensitive: B - Late Trials trabectedin Sensitive : B	trabectedin Sensitive: B - Late Trials trabectedin Sensitive : B

DNA inhibitor

DNA inhibitor

Associations(59)

Associations
(59)